Hunter C. Smith
Chief Financial Officer
SEC EDGAR ↗Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC., filing insider transactions between 2026-02-17 and 2026-02-19.
Total Purchases
—
0 transactions
Total Sales
$806K
9 transactions
Companies Traded
1
9 total filings
Active Since
2026-02-17
Last: 2026-02-19
Other Reporting Insiders at Rhythm Pharmaceuticals, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-02-19 | RYTM | Sale | 1,308 | $100.27 | $131K | 113.6K | SEC ↗ |
| 2026-02-19 | RYTM | Sale | 1,692 | $100.92 | $171K | 111.9K | SEC ↗ |
| 2026-02-19 | RYTM | Sale | 585 | $103.28 | $60K | 110.5K |
Corporate Controller & CAO
| 2026-02-17 | RYTM | Sale | 1,069 | $103.00 | $110K | 115.1K | SEC ↗ |
| 2026-02-17 | RYTM | Sale | 1,200 | $99.42 | $119K | 117.3K | SEC ↗ |
Hunter C. Smith (Rhythm Pharmaceuticals, Inc.) Insider Trades | Tormere